Frédéric Prince to Lead Neovii Pharmaceuticals as New CEO

Neovii Pharmaceuticals will see a leadership change as Frédéric Prince, PhD, takes over the role of CEO from Dr. Christian Loss on January 1st, 2026. Dr. Loss is retiring after a significant career with the company. Prince, previously Head of Strategy at Roche's Pharma Research and Early Development, brings a wealth of experience in oncology and biotechnology. He has also held key roles at Genetix Biotherapeutics and Novartis Oncology. His background includes a PhD in Molecular Genetics from the University of Basel. The Board of Directors expresses gratitude to Dr. Loss for his service and welcomes Dr. Prince, expecting continued growth and success for Neovii.